Capricorn Partners

Capricorn Partners is an independent venture capital firm based in Leuven, Belgium, founded in 1993. The firm specializes in managing pan-European venture capital funds, focusing on innovative technology-driven growth companies across various sectors, including healthcare, information technology, SaaS, manufacturing, life sciences, oncology, big data, clean technology, and digital health. Capricorn Partners boasts a team of experienced investment managers with extensive technology expertise and broad industrial backgrounds, enabling them to identify and support promising European companies that leverage technology as a competitive advantage.

Jan Avonts

Investment Director

Damien van der Bijl

Investment Director

Frank Bulens

Partner

Daniela Arruda Costa

Investment Associate

Olaf Cörper

Partner

Antoine D’Hollander

Investment Director

Katrin Geyskens

Partner

Steven Lambert

Investment Partner Digital

Maarten Lambert

Senior Associate

Steven Lambert

Senior Investment Manager

Marc Lambrechts

Senior Investment Manager

Steven Levecke

Partner

Rob van der Meij

Investment Manager

Jos B. Peeters

Founder and Managing Partner

Filip Pintelon

Investment Partner Health

Wouter Van de Putte

Investment Director

Johan Reynaert

Investment Manager

Daniel von Scheven

Investment Manager

Ekaterina Smirnyagina

Partner

Claude Stoufs

Partner

Leslie Totté

CFO

Yves Vaneerdewegh

Partner, Member of the Executive Committee and Board Member

Sabine Vermassen

Partner, Member of the Executive Committee and Board Member

Simon Wouters

Investment Analyst

Past deals in Belgium

StoryChief

Venture Round in 2022
StoryChief.io is a content marketing software designed for startups, SEO marketers, and editorial teams seeking to streamline their content creation and distribution processes. The platform enables users to publish stories across multiple channels, including WordPress, Medium, newsletters, and various social media platforms, all from a single interface. Its universal editor allows for the easy creation of visually appealing articles tailored for different publishing formats. Additionally, StoryChief offers features such as SEO suggestions, performance tracking, and lead capture integration with CRM systems, helping users measure their impact and return on investment effectively. By centralizing content management, StoryChief enhances the reach and efficiency of content marketing efforts.

Sensolus

Venture Round in 2020
Sensolus NV designs and develops global positioning system (GPS) trackers that allows to track non-powered assets. It offers turnkey solutions for wireless and low-power context-aware sensing. The company also provides a web based platform, Internet of things (IoT) cloud platform, and application that helps to provide real time information about assets. It serves manufacturing, waste management, cargo transport, transport and logistics, and automotive industry. The company was founded in 2013 and is based in Ghent, Belgium.

ViroVet

Series B in 2020
ViroVet NV develops virus control solutions for the livestock industry. It offers antiviral drugs for the control and treatment of respiratory diseases of cattle and swine. The company also offers modified live virus vaccines for endemic and epizootic viral livestock diseases. ViroVet NV was founded in 2015 and is based in Leuven, Belgium.

iSTAR Medical

Series C in 2019
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Arkite

Venture Round in 2019
Arkite NV manufactures automation products, Human Interface Mate, which assists the manufacturing operator by warning as soon as a wrong operation is in progress and navigates towards standardized work. The company was founded in 2015 and is based in Genk, Belgium.

icometrix

Series A in 2019
Icometrix is a company based in Leuven, Belgium, specializing in the development of automated MRI biomarkers for neurological disorders. Founded in 2011 as a spin-off from the universities and university hospitals of Leuven and Antwerp, the company provides standardized measurements of brain MRI scans to enhance personalized care for patients with conditions such as multiple sclerosis, dementia, and traumatic brain injury. Its key products include icobrain ms, which tracks disease progression in multiple sclerosis patients; cobrain dm, which quantifies brain structures in dementia patients; and icobrain tbi, which monitors axonal injuries in head trauma cases. Icometrix has gained international recognition for its solutions, which are widely used in clinical practice and research, including clinical trials for new drug development. The company is ISO certified for quality management and information security, and its software-as-a-service platform enables efficient processing of large volumes of brain imaging data, contributing to advancements in the understanding and treatment of neurological disorders.

Confo Therapeutics

Series A in 2019
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO® technology, Confo Therapeutics stabilizes inherently unstable functional conformations of GPCRs, providing a robust starting point for drug discovery. This approach reveals previously inaccessible structural features of these receptors, facilitating the identification of novel agonists that enhance therapeutic interventions.

Miaa Guard

Venture Round in 2019
Miaa Guard CVBA, based in Leuven, Belgium, develops a cloud-based platform that provides access control solutions for digital businesses. The platform utilizes microservice APIs to manage access rights and policies tailored to both consumers and professionals within an enterprise context. It enables organizations to govern security and access, integrate data architecture, and customize configurations. Founded in 2009 and originally known as VintiQ, the company rebranded to Miaa Guard CVBA in 2014. Its services facilitate the monetization of digital assets while ensuring proper authorization among users.

LindaCare

Series B in 2018
LindaCare LTD. is a Belgium-based company that specializes in developing a tele-monitoring dashboard for patients with chronic diseases, particularly those with cardiac implantable devices. The software integrates data from various device vendors and electronic patient records, enhancing workflow efficiency and reducing the risk of medical errors through customized alerts. By offering a vendor-independent platform, LindaCare aims to simplify the tele-monitoring process for healthcare professionals and hospitals, ultimately reducing the cost of care delivery while improving patient safety and the overall quality of care. This unified approach facilitates better tracking and monitoring of patient activities, benefiting both healthcare providers and family members involved in patient care management.

NGDATA

Series C in 2017
NGDATA is a company that specializes in consumer intelligence management solutions, focusing on data-driven sectors such as retail, finance, media, and telecommunications. The company has developed Lily, a big data management system that extracts real-time business insights and enhances data utility. By combining big data management with machine learning technologies, NGDATA provides enterprises with a comprehensive platform to improve customer experience management. This platform delivers insights on both historical and real-time customer interactions, allowing organizations to engage with customers more effectively and drive customer loyalty. Headquartered in Ghent, Belgium, NGDATA also has offices in Singapore, Paris, New York City, and San Francisco.

Arkite NV

Venture Round in 2017
They believe a strong team makes for an even stronger product. Each and every one of our employees represent the spirit of Arkite NV: committed and passionate about bringing you the autonomation solution that helps your operators perform their job better. The team has a seasoned background in industrial engineering, lean thinking and process innovation. For implementation of the Arkite HIM product Professional Services are offered as an option. These include: Process Innovation Consultancy, Integration Services, Training and Operations during start up time.They also assist our customers with time study (MTM) for technology innovation, knowledge management to improve the quality system (eliminate scrap) and organizational innovation by introducing new work forms to decrease throughput time.

Sensolus

Seed Round in 2017
Sensolus NV designs and develops global positioning system (GPS) trackers that allows to track non-powered assets. It offers turnkey solutions for wireless and low-power context-aware sensing. The company also provides a web based platform, Internet of things (IoT) cloud platform, and application that helps to provide real time information about assets. It serves manufacturing, waste management, cargo transport, transport and logistics, and automotive industry. The company was founded in 2013 and is based in Ghent, Belgium.

ViroVet

Series A in 2017
ViroVet NV develops virus control solutions for the livestock industry. It offers antiviral drugs for the control and treatment of respiratory diseases of cattle and swine. The company also offers modified live virus vaccines for endemic and epizootic viral livestock diseases. ViroVet NV was founded in 2015 and is based in Leuven, Belgium.

FEops

Series B in 2017
FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians. Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.

NGDATA

Series B in 2017
NGDATA is a company that specializes in consumer intelligence management solutions, focusing on data-driven sectors such as retail, finance, media, and telecommunications. The company has developed Lily, a big data management system that extracts real-time business insights and enhances data utility. By combining big data management with machine learning technologies, NGDATA provides enterprises with a comprehensive platform to improve customer experience management. This platform delivers insights on both historical and real-time customer interactions, allowing organizations to engage with customers more effectively and drive customer loyalty. Headquartered in Ghent, Belgium, NGDATA also has offices in Singapore, Paris, New York City, and San Francisco.

Indigo Diabetes

Series A in 2016
Indigo Diabetes nv is a medical device company based in Ghent, Belgium, founded in 2016 by Danaë Delbeke and her team. The company specializes in developing an innovative invisible glucose monitor that utilizes advanced photonics technology to measure and manage blood glucose levels without the need for finger pricks. This high-tech sensor is designed to be inserted under the skin, allowing for continuous monitoring of blood sugar levels. Indigo Diabetes aims to enhance the user experience for individuals living with diabetes by providing a more accurate and convenient method for glucose monitoring, thereby transforming diabetes management.

FRX Innovations

Series D in 2016
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

Diagenode

Venture Round in 2016
Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office in the United Kingdom to better serve this specific country. Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies. Epigenetics Division

iSTAR Medical

Series B in 2016
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

LindaCare

Series A in 2015
LindaCare LTD. is a Belgium-based company that specializes in developing a tele-monitoring dashboard for patients with chronic diseases, particularly those with cardiac implantable devices. The software integrates data from various device vendors and electronic patient records, enhancing workflow efficiency and reducing the risk of medical errors through customized alerts. By offering a vendor-independent platform, LindaCare aims to simplify the tele-monitoring process for healthcare professionals and hospitals, ultimately reducing the cost of care delivery while improving patient safety and the overall quality of care. This unified approach facilitates better tracking and monitoring of patient activities, benefiting both healthcare providers and family members involved in patient care management.

NGDATA

Series B in 2015
NGDATA is a company that specializes in consumer intelligence management solutions, focusing on data-driven sectors such as retail, finance, media, and telecommunications. The company has developed Lily, a big data management system that extracts real-time business insights and enhances data utility. By combining big data management with machine learning technologies, NGDATA provides enterprises with a comprehensive platform to improve customer experience management. This platform delivers insights on both historical and real-time customer interactions, allowing organizations to engage with customers more effectively and drive customer loyalty. Headquartered in Ghent, Belgium, NGDATA also has offices in Singapore, Paris, New York City, and San Francisco.

Ogeda

Series B in 2015
Ogeda SA, a clinical-stage drug discovery company, invents and develops small molecule drugs targeting G-Protein Coupled Receptors. It offers fezolinetant (ESN364), a Phase II clinical development product for the treatment of women’s health disorders; NK3 antagonists for the treatment of hormone-dependent pathologies in women's health; and products for endocrine, CNS/inflammatory disorders. Ogeda SA was formerly known as Euroscreen SA and changed its name to Ogeda SA in October 2016. The company was founded in 1994 and is based in Gosselies, Belgium. It has a meeting facility in Brussels, Belgium; and an additional office in Paris, France. Ogeda SA operates as a subsidiary of Astellas Pharma Inc.

NovoPolymers

Venture Round in 2015
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

FEops

Series A in 2015
FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians. Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.

FRX Innovations

Series C in 2014
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

iSTAR Medical

Series A in 2013
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Trod Medical

Series B in 2013
Trod Medical S.A. is a medical equipment and surgical device manufacturer founded in 2006, with headquarters in Leuven, Belgium, and a presence in the Tampa Bay area, USA. The company specializes in developing innovative ablation technologies, particularly focusing on radiofrequency (RF) ablation devices. Trod Medical's flagship product, the EncageTM, is a disruptive percutaneous RF device that enables precise tissue ablation, significantly reducing collateral damage—a critical concern in treatments for conditions such as prostate cancer. With prostate cancer being one of the most prevalent cancers, affecting approximately 240,000 new patients annually in the United States, Trod Medical's technology addresses the limitations of conventional treatments that often lead to severe side effects, including erectile dysfunction and urinary incontinence. The company aims to enhance patient outcomes through its advanced medical devices designed for the focal ablation of soft tissues.

NGDATA

Series A in 2013
NGDATA is a company that specializes in consumer intelligence management solutions, focusing on data-driven sectors such as retail, finance, media, and telecommunications. The company has developed Lily, a big data management system that extracts real-time business insights and enhances data utility. By combining big data management with machine learning technologies, NGDATA provides enterprises with a comprehensive platform to improve customer experience management. This platform delivers insights on both historical and real-time customer interactions, allowing organizations to engage with customers more effectively and drive customer loyalty. Headquartered in Ghent, Belgium, NGDATA also has offices in Singapore, Paris, New York City, and San Francisco.

Trinean

Venture Round in 2012
Trinean is a Belgium based technology provider, bringing micro-volume molecular spectroscopy to the next level by combining best in class analytical software with a highly standardized read-out platform. Founded in 2006 as a spin-out of the Ghent University, Belgium and Imec Leuven, Belgium, the company commercializes UV/VIS spectrometers for biomolecule quantification. The DropSense™16 and DropSense™96, analyzing up to 16 and 96 samples resp., use microfluidic chips for standardized sample analysis (DropPlates™ and Slides). The Trinean platform is complemented with a software toolbox for improved data interpretation and lab-automation.

NovoPolymers

Venture Round in 2012
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

EpiGan

Venture Round in 2011
EpiGaN is a Leuven, Belgium-based company that specializes in the development of Gallium Nitride on Silicon (GaN) wafers. The company produces III-nitride epitaxial materials, primarily gallium nitride, which are known for their high power efficiency and reduced power losses. These materials are suited for a range of commercial applications, including AC drives, uninterruptible power supply (UPS) inverters, and hybrid and electric vehicles. EpiGaN's innovative technology aims to enhance performance and efficiency in various electronic systems.

FRX Innovations

Series B in 2011
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

NovoPolymers

Series B in 2011
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Ducatt

Venture Round in 2010
Ducatt NV is a Belgium-based start-up specializing in the manufacturing of solar glasses designed to enhance the efficiency of solar systems. The company offers ultra-clear patterned glasses available in various thicknesses, allowing clients to choose products that meet their specific needs while ensuring affordability. By focusing on innovative glass solutions for the solar industry, Ducatt aims to contribute to the advancement of renewable energy technologies.

FRX Innovations

Series A in 2009
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

NovoPolymers

Series A in 2009
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

iNEWiT

Venture Round in 2008
iNEWiT is an engineering company based in Mechelen, Belgium, founded in 2005. The company specializes in identifying, designing, and creating applications and devices for the mobile market. It develops mobile video communication applications and offers a range of wireless communication technologies, including GPRS/EDGE, 3G, HSDPA/HSUPA, WiFi, WiMAX, and satellite networks. iNEWiT's products utilize patent-pending technology to transmit data, video, and sound across various wireless and wired environments and platforms. Additionally, the company provides plug-and-play products tailored for the business-to-consumer markets.

Clear2Pay

Series D in 2006
Clear2Pay is a payments technology company that specializes in providing innovative solutions for secure and efficient payment processing. Its key offering, the Open Payment Framework (OPF), allows financial institutions to enhance their internal payment processing while delivering improved services to clients, characterized by speed and detailed payment information. The OPF employs a centralized payments engine supported by a library of reusable business services, enabling banks to integrate new service models with their existing infrastructures. This approach helps institutions modernize their payment systems while safeguarding previous investments. Additionally, Clear2Pay offers a Software Development Kit and a Bank Payment Hub, which facilitate customer interaction, order management, and payment execution, along with services for dispute and exception processing.

Gemidis

Series C in 2006
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

TiGenix

Venture Round in 2003
TiGenix NV (TiGenix) and its subsidiaries TiGenix Inc. and TC CEF LLC. is a Belgium-based biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints. The Company is exploiting the power of regenerative medicine for the development of durable treatments, validated through controlled clinical studies, for these indications. TiGenix is located in Leuven and was founded as a spin-off of the Catholic University of Leuven and the University of Ghent. TiGenix is developing a portfolio of products that addresses specific musculoskeletal problems. The lead indication among these is cartilage damage, which is a debilitating affliction severely affecting the mobility and functioning of patients. During the fiscal year ended December 31, 2009, the Company acquired Orthomimetics Ltd.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.